Evidence map›Paper›PMID 30410016›Full record

ArticleProstate cancer and prostatic diseases2019

Impact of lower urinary tract symptoms on mortality: a 21-year follow-up among middle-aged and elderly Finnish men.

Jonne Åkerla, Jori S Pesonen, Antti Pöyhönen, Jukka Häkkinen, Juha Koskimäki, Heini Huhtala, Teuvo L J Tammela, Anssi Auvinen

Abstract read
PubMed Publisher
In one paragraph

Article in Prostate cancer and prostatic diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Jonne ÅkerlaDepartment of Surgery, Central Finland Central Hospital, Jyväskylä, Finland. jonne.akerla@fimnet.fi.ORCID http://orcid.org/0000-0002-0861-6569
Jori S PesonenDepartment of Surgery, Päijät-Häme Central Hospital, Lahti, Finland.
Antti PöyhönenDepartment of Surgery, Central Finland Central Hospital, Jyväskylä, Finland.
Jukka HäkkinenDepartment of Urology, Turku University Hospital, Turku, Finland.
Juha KoskimäkiDepartment of Urology, Tampere University Hospital, Tampere, Finland.
Heini HuhtalaFaculty of Social Sciences, University of Tampere, Tampere, Finland.
Teuvo L J TammelaFaculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Anssi AuvinenFaculty of Social Sciences, University of Tampere, Tampere, Finland.
Tampere University · FITampere University Hospital · FICentral Finland Health Care District · FITampere University of Applied Sciences · FITurku University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe usefulness of lower urinary tract symptoms (LUTS) as mortality risk factors remains unclear. Repeated assessments are required to take into account symptom fluctuation and de novo symptom appearance. The study objective was to evaluate mortality in relation to three urinary storage symptoms-urgency, daytime frequency, and nocturia-in middle-aged and elderly men, considering also other time-varying factors during follow-up.

methodsA mail survey of a population-based cohort of men initially aged 50, 60, and 70 years was conducted in Finland in 1994, 1999, 2004, and 2009. The questionnaire included assessments of LUTS based on the Danish Prostatic Symptom Score and comorbidities. The men were followed up for mortality through the population registry through 2014. LUTS-related hazard ratios (HR) were analyzed with time-dependent Cox regression adjusted for the year of birth and comorbidities using variable values updated every 5 years. Sensitivity analyses were conducted using values of all variables fixed to the baseline assessment of 1994.

resultsOf the 1332 eligible men with data on LUTS from each preceding survey, 514 (38.6%) died during the 21-year follow-up. In time-dependent analyses, daytime frequency, and nocturia were significantly associated with increased mortality: the adjusted HR was 1.42 (95% CI 1.11-1.83) for daytime frequency, 1.38 (1.07-1.79) for nocturia and 1.19 (0.94-1.50) for urgency. In sensitivity analyses with fixed baseline characteristics, only nocturia was suggestively associated with an increased risk of death: the adjusted HR was 1.09 (0.84-1.42) for daytime frequency, 1.41 (0.99-2.02) for nocturia and 0.94 (0.52-1.68) for urgency.

conclusionsAmong aging men, LUTS are more accurate predictors of short-term than longer-term mortality risk. Repeated assessments are needed to detect clinically relevant and persistent symptoms, often associated with ill health. Accordingly, men with daytime frequency or nocturia exhibit a 1.4-fold risk of death and therefore, should be evaluated for underlying comorbidity.

Indexed as

AgedAged, 80 and overComorbidityFinlandFollow-Up StudiesHumansKaplan-Meier EstimateLower Urinary Tract SymptomsMaleMiddle AgedPopulation SurveillanceProportional Hazards Models

Identifiers

PMID30410016
OpenAlexW2900198335

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.